MSA
CL icon

Marino Stram & Associates’s Colgate-Palmolive CL Stock Holding History

Marino Stram & Associates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$571K Buy
6,231
+20
+0.3% +$1.75K 0.09% 114
2026
Q1 		$529K Buy
6,211
+1
+0% +$89 0.1% 111
2025
Q4 		$491K Sell
6,210
-90
-1% -$7.06K 0.09% 117
2025
Q3 		$504K Buy
6,300
+32
+0.5% +$2.73K 0.09% 122
2025
Q2 		$570K Buy
6,268
+17
+0.3% +$1.55K 0.12% 109
2025
Q1 		$586K Buy
6,251
+18
+0.3% +$1.61K 0.13% 106
2024
Q4 		$567K Buy
6,233
+16
+0.3% +$1.53K 0.13% 107
2024
Q3 		$645K Buy
6,217
+15
+0.2% +$1.53K 0.14% 102
2024
Q2 		$602K Buy
6,202
+11
+0.2% +$1.01K 0.15% 100
2024
Q1 		$558K Hold
6,191
– – 0.13% 105
2023
Q4 		$493K Sell
6,191
-262
-4% -$19.7K 0.13% 106
2023
Q3 		$459K Buy
6,453
+154
+2% +$11.5K 0.13% 105
2023
Q2 		$485K Buy
6,299
+181
+3% +$14K 0.14% 104
2023
Q1 		$460K Buy
6,118
+1
+0% +$74 0.14% 103
2022
Q4 		$482K Buy
6,117
+2
+0% +$150 0.15% 99
2022
Q3 		$430K Buy
6,115
+1
+0% +$78 0.16% 94
2022
Q2 		$490K Buy
6,114
+1
+0% +$78 0.17% 95
2022
Q1 		$464K Buy
6,113
+52
+0.9% +$4.12K 0.15% 104
2021
Q4 		$517K Buy
6,061
+164
+3% +$12.8K 0.16% 100
2021
Q3 		$446K Buy
5,897
+1,055
+22% +$83.8K 0.15% 100
2021
Q2 		$394K Sell
4,842
-835
-15% -$68.3K 0.1% 154
2021
Q1 		$448K Buy
5,677
+658
+13% +$51.6K 0.18% 87
2020
Q4 		$429K Sell
5,019
-28
-0.6% -$2.31K 0.19% 79
2020
Q3 		$389K Buy
5,047
+133
+3% +$10.1K 0.21% 73
2020
Q2 		$360K Buy
+4,914
New +$349K 0.21% 71
2019
Q2 		– Sell
-176
Closed -$12K – 161
2019
Q1 		$12K Buy
176
+16
+10% +$1.03K 0.01% 291
2018
Q4 		$10K Hold
160
– – 0.01% 274
2018
Q3 		$11K Buy
160
+1
+0.6% +$67 0.01% 291
2018
Q2 		$10K Buy
159
+1
+0.6% +$65 0.01% 298
2018
Q1 		$11K Sell
158
-5
-3% -$360 0.01% 299
2017
Q4 		$12K Buy
+163
New +$11.9K 0.01% 292

Other funds holding CL

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM

Marino Stram & Associates's CL Position: Q2 2026 in Review

Marino Stram & Associates increased its Colgate-Palmolive (CL) stake by 0.32% in Q2 2026, buying an estimated $1.75K and bringing the position to 6,231 shares worth $571K. The position accounts for 0.09% of the portfolio, ranked #114.

Marino Stram & Associates first reported a position in CL in Q4 2017 and has held it in 31 quarters since. The position peaked at $645K in Q3 2024. 895 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Marino Stram & Associates held 6,231 shares of Colgate-Palmolive worth $571K as of Q2 2026.
  • Marino Stram & Associates bought 20 Colgate-Palmolive shares in Q2 2026, an estimated $1.75K.
  • Colgate-Palmolive made up 0.09% of Marino Stram & Associates's portfolio in Q2 2026, its #114 holding.
  • Marino Stram & Associates first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 31 quarters since.
  • Marino Stram & Associates's Colgate-Palmolive position peaked at $645K in Q3 2024.
  • 895 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Marino Stram & Associates's 13F filing for Q2 2026, filed 24 Jul 2026.